Remolta, Ailyn A.

HRN: 28-51-17  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2026
OXACILLIN 500MG (VIAL)
02/08/2026
02/14/2026
IV
500mg
Q6
Infected Wound Left Breast
Checking Initial Appropriateness 

 Indication:  Culture-directed    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines